Javascript must be enabled to continue!
Platelet-Rich Plasma Therapy for Male Sexual Dysfunction: Myth or Reality?
View through CrossRef
ABSTRACTIntroductionPlatelet-rich plasma (PRP) found its use in treating different conditions and diseases, because concentrated plasma PRP consists of many growth factors. Their interaction with surrounding cells, intracellular matrix, and mediators at the site of injection leads to tissue regeneration. Angiogenic, vasculogenic, and regenerative effects of PRP may be used for erectile dysfunction (ED) and Peyronie’s disease (PD) treatment.AimTo present a current data review of preclinical and clinical trials on PRP use for treating ED and PD.MethodsUp-to-date literature on PRP use for ED and PD treatment was analyzed. The search was based on Pubmed, Cochrane Library, clinicaltrials.gov databases, with the following key words: “platelet-rich plasma” and/or “erectile dysfunction” and/or “Peyronie’s disease” and/or “sexual dysfunction.”Main Outcome MeasuresThe main outcome measures for preclinical trials on ED were erectile function, assessed with intracavernous pressure, and pathologic analysis of penile tissue. The main outcome measures for clinical trials on ED included penile duplex Doppler ultrasound scanning and validated questionnaires. The main outcome measures on PD were pathologic analysis of penile tissue for preclinical trials, as well as penile duplex Doppler ultrasound scanning, penile curvature angle measuring, and validated questionnaires for clinical trials.Results4 preclinical and 6 clinical trials were described and analyzed in this article. Limitations for both preclinical and clinical trials included small groups, short follow-up periods, a lack of control groups or groups with placebo, and the lack of quality and quantity analysis of PRP.ConclusionAvailable data show the lack of adverse reactions with PRP treatment. The studies that we found were limited by small groups. This is why the data on safety and effectiveness should be taken carefully. However, it is important to mention that PRP therapy has the potential for treating male sexual dysfunction and may be useful in andrology.
Oxford University Press (OUP)
Title: Platelet-Rich Plasma Therapy for Male Sexual Dysfunction: Myth or Reality?
Description:
ABSTRACTIntroductionPlatelet-rich plasma (PRP) found its use in treating different conditions and diseases, because concentrated plasma PRP consists of many growth factors.
Their interaction with surrounding cells, intracellular matrix, and mediators at the site of injection leads to tissue regeneration.
Angiogenic, vasculogenic, and regenerative effects of PRP may be used for erectile dysfunction (ED) and Peyronie’s disease (PD) treatment.
AimTo present a current data review of preclinical and clinical trials on PRP use for treating ED and PD.
MethodsUp-to-date literature on PRP use for ED and PD treatment was analyzed.
The search was based on Pubmed, Cochrane Library, clinicaltrials.
gov databases, with the following key words: “platelet-rich plasma” and/or “erectile dysfunction” and/or “Peyronie’s disease” and/or “sexual dysfunction.
”Main Outcome MeasuresThe main outcome measures for preclinical trials on ED were erectile function, assessed with intracavernous pressure, and pathologic analysis of penile tissue.
The main outcome measures for clinical trials on ED included penile duplex Doppler ultrasound scanning and validated questionnaires.
The main outcome measures on PD were pathologic analysis of penile tissue for preclinical trials, as well as penile duplex Doppler ultrasound scanning, penile curvature angle measuring, and validated questionnaires for clinical trials.
Results4 preclinical and 6 clinical trials were described and analyzed in this article.
Limitations for both preclinical and clinical trials included small groups, short follow-up periods, a lack of control groups or groups with placebo, and the lack of quality and quantity analysis of PRP.
ConclusionAvailable data show the lack of adverse reactions with PRP treatment.
The studies that we found were limited by small groups.
This is why the data on safety and effectiveness should be taken carefully.
However, it is important to mention that PRP therapy has the potential for treating male sexual dysfunction and may be useful in andrology.
Related Results
PREPARATION AND IN VITRO WOUND HEALING EFFECTS OF ANIMAL-BASED PLATELET-RICH PLASMA LYSATE
PREPARATION AND IN VITRO WOUND HEALING EFFECTS OF ANIMAL-BASED PLATELET-RICH PLASMA LYSATE
Wound healing is a vital field of study in both human and veterinary medicine, particularly in the treatment of chronic wounds. Platelet-rich plasma, known for its potential to enh...
(184) The Prevalence of Sexual Dysfunction in Women Seeking Infertility Treatment in Vietnam
(184) The Prevalence of Sexual Dysfunction in Women Seeking Infertility Treatment in Vietnam
Abstract
Introduction
Sexual function plays a crucial role in women's psychosocial and overall well-being, significantly impacti...
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
(English) Spacecraft entering planetary atmospheres are enveloped by a plasma layer with high levels of ionization, caused by the extreme temperatures in the shock layer. The charg...
Appearance of Platelet-Clumping Substance after Acidification of Plasma
Appearance of Platelet-Clumping Substance after Acidification of Plasma
Abstract
1. The pH values of heparinized plasma from ten normal rabbits were from 7.53 to 7.80. The average pH and standard error was 7.69 ± 0.03. These plasmas did ...
Autoimmune thrombocytopenic purpura
Autoimmune thrombocytopenic purpura
Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposition following an enviro...
Autoimmune thrombocytopenic purpura
Autoimmune thrombocytopenic purpura
Abstract
Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposi...
Cytology and histology characteristics of platelet-rich fibrin
Cytology and histology characteristics of platelet-rich fibrin
Background: Platelet-rich fibrin (PRF) is a biomaterial whose frame is a network of fibrin fibers containing cells from peripheral blood and growth factors. PRF biomaterials have g...
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Plasma and platelet factor Va represent different substrates for activated protein C (APC). In this study, we have measured platelet-dependent APC resistance and the effect of aspi...

